Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Le Groupe Français pour l'Etude du Traitement des Hépatites Chroniques NANB/C.

@article{Jout1994ComparativeEO,
  title={Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Le Groupe Français pour l'Etude du Traitement des H{\'e}patites Chroniques NANB/C.},
  author={P Jou{\"e}t and Françoise Roudot-Thoraval and Daniel Dhumeaux and Jean Michel Metreau},
  journal={Gastroenterology},
  year={1994},
  volume={106 3},
  pages={686-90}
}
BACKGROUND/AIMS Because the effects of interferon in the presence and absence of cirrhosis are still debated in chronic active hepatitis type non-A, non-B, C (NANB/C), the aim of this study was to determine to what extent the presence of cirrhosis influences the response to interferon. METHODS We compared the response to interferon alfa in 108 patients with chronic active hepatitis NANB/C with or without cirrhosis. The patients were randomly assigned to one of the two regimens: one group… CONTINUE READING